International experts have hailed the study, which began in 2015, as a significant advancement in the adjuvant treatment of ...

Researchers at Baylor College of Medicine and collaborating institutions have uncovered new potential therapeutic targets for cancer and new insights into existing cancer drug targets, expanding the ...

Tom Hanson is a national investigative correspondent for CBS News and Stations. His in-depth reports air across all platforms and programs. He is a member of CBS News and Stations Medical, Health, and ...

MimiVax, Inc. is developing immunotherapeutic vaccines and targeted therapies for treating cancers and preventing recurrence. The company’s lead agent, SurVaxM, targets survivin, a cell-survival ...

Agreement creates strong synergies between CureVac's unique end-to-end mRNA capabilities and MD Anderson's translational and clinical research expertise Collaboration aims to develop novel, ...

Survivors of breast cancer are at significantly higher risk of developing second cancers, including endometrial and ovarian cancer for women and prostate cancer for men, according to new research ...

BOSTON - A new study finds that people with breast cancer are more likely to develop a second cancer over time. Researchers at the University of Cambridge analyzed data on more than 583,000 female and ...

Doctors are seeing colon cancer in people in their 20s and 30s. New research suggests it starts in infancy.

He's promised to put Americans on Mars and end the wars in Ukraine and the Middle East. But Donald Trump's most impactful ...